- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Pharmacological intervention
- Vaccination
- Nasal vaccine
Population: General population
Individuals who do not belong to a defined subgroup with specific characteristics, representing the broader population
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Apo-Si-K170A-C76
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- SARS-CoV-2
- Non pharmacological intervention
- Rehabilitation
- Education
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Community
- General population
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Emergency department
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Influenza virus
- Influenza
- COVID-19
- Blood sample
- Nasopharyngeal swab
- General population
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Emergency department
- Diagnostics
- Point of care tests
- General population
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Influenza virus
- Adenovirus
- Rhinovirus
- Enterovirus
- Human coronavirus NL63
- Streptococcus pyogenes
- Influenza
- COVID-19
- Adenovirus infection
- Rhinovirus infection
- Enterovirus infection
- Streptococcus pyogenes infection
- Diagnostics
- Point of care tests
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Community
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Respiratory syncytial virus infection
- Influenza
- COVID-19
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Influenza virus
- Streptococcus pneumoniae
- Influenza
- Streptococcus pneumoniae infection
- Pharmacological intervention
- Vaccination
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Primary care
- Respiratory syncytial virus
- Influenza virus
- Respiratory syncytial virus infection
- Influenza
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- SARS-CoV-2
- COVID-19